Supernus Pharmaceuticals Ratios (2011-2026) | SUPN

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Ratios	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Profitability
Gross Margin (Quarter)	82.29%	87.82%	89.32%	88.24%	87.97%	85.41%	86.28%	84.74%	84.44%	87.26%	88.06%	88.65%	89.36%	89.99%	85.01%	89.48%	89.83%	90.13%	89.13%
EBT Margin (Quarter)	22.10%	19.51%	1.29%	9.65%	6.66%	-0.25%	21.00%	5.86%	-12.63%	6.43%	0.60%	0.17%	15.63%	25.58%	15.15%	-3.89%	10.07%	-30.17%	-0.90%
EBIT Margin (Quarter)	24.14%	21.96%	3.83%	1.29%	6.67%	-0.86%	20.52%	3.37%	-12.97%	5.29%	-0.61%	-2.20%	13.41%	23.25%	12.29%	-6.85%	7.34%	-31.35%	-1.86%
EBITDA Margin (Quarter)	24.14%	21.96%	3.83%	1.29%	6.67%	-0.86%	20.52%	3.37%	-12.97%	5.29%	-0.61%	-2.20%	13.41%	23.25%	12.29%	-7.87%	7.34%	-31.35%	-1.86%
Operating Margin (Quarter)	24.14%	21.96%	3.83%	1.29%	6.67%	-0.86%	20.52%	3.37%	-12.97%	5.29%	-0.61%	-2.20%	13.41%	23.25%	12.29%	-6.85%	7.34%	-31.35%	-1.86%
Net Margin (Quarter)	16.79%	14.52%	1.54%	16.80%	4.60%	0.99%	15.24%	11.00%	-0.61%	-10.40%	0.69%	0.09%	11.82%	21.94%	8.80%	-7.89%	13.60%	-23.49%	-1.95%
FCF Margin (Quarter)	32.74%	-2.77%	30.66%	2.46%	41.98%	7.63%	16.57%	31.77%	-14.04%	23.22%	27.38%	26.56%	21.13%	30.35%	25.38%	20.21%	35.10%	-32.17%	9.19%
Efficiency
Inventory Average (Quarter)	54.31M	59.27M	73.06M	87.38M	86.83M	84.01M	87.35M	91.34M	90.85M	87.02M	80.44M	76.24M	71.62M	66.07M	59.14M	51.86M	46.72M	61.71M	80.89M	84.72M
Assets Average (Quarter)	1,540.25M	1,564.05M	1,622.10M	1,664.33M	1,667.24M	1,694.05M	1,697.82M	1,747.16M	1,542.45M	1,289.13M	1,281.42M	1,290.88M	1,309.96M	1,329.27M	1,355.39M	1,357.68M	1,364.85M	1,401.08M	1,436.20M	1,476.69M
Equity Average (Quarter)	770.01M	798.02M	813.16M	822.15M	834.94M	847.12M	869.50M	899.18M	916.03M	916.05M	916.85M	925.34M	943.31M	982.30M	1,021.44M	1,033.22M	1,047.30M	1,056.78M	1,055.69M	1,069.26M
Invested Capital (Quarter)	809.12M	834.04M	1,195.10M	875.34M	1,242.34M	1,254.24M	907.32M	912.15M	940.63M	958.07M	973.59M	980.54M	1,004.76M	1,053.73M	1,083.07M	1,060.70M	1,063.90M	1,060.90M	1,092.77M	1,076.81M
Asset Utilization Ratio (Quarter)	0.37	0.36	0.36	0.36	0.38	0.39	0.39	0.38	0.41	0.47	0.47	0.46	0.48	0.49	0.49	0.49	0.49	0.49	0.50
Leverage & Solvency
Interest Coverage Ratio (Quarter)	6.24	5.50	1.03	1.01	6.27	-0.88	21.54	3.44	-19.33
Debt to Equity (Quarter)	0.03	0.03	0.52	0.06	0.48	0.06	0.02		0.02	0.05	0.06	0.06	0.05	0.05	0.05	0.03		0.01	0.03
Debt Ratio (Quarter)	0.01	0.02	0.25	0.03	0.24	0.03	0.01		0.02	0.04	0.04	0.04	0.04	0.03	0.03	0.02		0.01	0.02
Equity Ratio (Quarter)	0.50	0.52	0.48	0.51	0.50	0.50	0.52	0.51	0.71	0.71	0.72	0.71	0.73	0.75	0.76	0.77	0.77	0.74	0.73	0.72
Times Interest Earned (Quarter)	6.24	5.50	1.03	1.01	6.27	-0.88	21.54	3.44	-19.33
Valuation
Enterprise Value (Quarter)	-409.84M	-443.85M	-339.68M	-312.20M	-360.79M	-391.79M	-461.33M	-228.57M	-151.66M	-200.19M	-254.87M	-297.74M	-347.19M	-403.21M	-453.61M	-463.59M	-522.60M	-281.16M	-308.67M	-384.24M
Return Ratios
Return on Sales (Quarter)	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Capital Employed (Quarter)	11.65%	9.25%	6.58%	5.42%	5.58%	1.85%	4.57%	4.86%	1.58%	3.00%	-0.53%	-1.39%	2.65%	5.71%	7.68%	6.93%	5.95%	-3.45%	-5.67%
Return on Invested Capital (Quarter)	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Assets (Quarter)	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Equity (Quarter)	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Research Tools

Supernus Pharmaceuticals Ratios (2011-2026) | SUPN

Create an account

Sign In

Reset Password